Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 26 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Impact of upper endoscopy on patient satisfaction

In patients with previously uninvestigated dyspepsia, endoscopy leads to improved patient satisfaction, find researchers in the March issue of Gastrointestinal Endoscopy.

News image

fiogf49gjkf04

In patients with uninvestigated dyspepsia who undergo endoscopy any abnormal findings guide management. However, upper endoscopy is "negative" in the majority of these patients.

In this study, researchers from Texas, USA, evaluated the impact of endoscopy on patient satisfaction in patients with uninvestigated dyspepsia.

The research team performed a secondary analysis of data obtained from a double-blind, randomized placebo-controlled trial.

In the study, a 6-week course of omeprazole versus placebo was evaluated in 140 patients with uninvestigated dyspepsia. Patients were followed for up to 1 year.

Similar improvements in satisfaction were observed in subgroups with both negative and positive findings.
Gastrointestinal Endoscopy

Study participants were 18 years of age or older, with at least a 1-week history of dyspepsia without alarm features.

The team measured satisfaction at each visit, using a validated, reliable dyspepsia-related health measure, which included a satisfaction scale.

Patients unresponsive to empiric therapy with placebo or omeprazole underwent endoscopy.

The team analyzed satisfaction scores for 5 visits. Scores were measured twice before the day of endoscopy (time 1 and time 2), immediately before endoscopy (time 3), and twice after endoscopy (times 4 and 5).

The team determined that there was no difference in treatment failure rates between patients who received placebo or omeprazole. They combined the data from these groups.

The mean satisfaction scores for times 1 through 5, in all patients who underwent endoscopy were compared. Subgroups with positive and negative endoscopic findings were also compared.

Data for all 5 visits were available for 62 patients, 36 of whom had a negative endoscopy.

The research team found that, for all patients, the mean scores for time 2 (8.5) and time 3 (7.6) were significantly lower than those for times 4 (13.7) and (14.4).

In addition, the mean score for time 1 (11.1) was significantly lower than the mean score for time 5.

Furthermore, similar significant improvements in satisfaction scores were observed in subgroups with negative and positive findings.

Dr Linda Rabeneck's team concludes, "In patients with previously uninvestigated dyspepsia, endoscopy leads to improved patient satisfaction regardless of the endoscopic findings".

Gastrointest Endosc 2003; 57: 295-9
05 March 2003

Go to top of page Email this page Email this page to a colleague

 26 February 2018 
Metabolic effects of new therapies of NASH
 26 February 2018 
Hepatocellular carcinoma risk in Hep B
 26 February 2018 
Novel targets for hepatocellular carcinoma
 23 February 2018 
Patients on antithrombotic agents undergoing emergency and elective endoscopy
 23 February 2018 
Heavy metals on a gluten-free diet
 23 February 2018 
MRI and NAFLD
 22 February 2018 
Outcomes with Crohn’s after infliximab withdrawal
 22 February 2018 
Elderly onset of IBD

 22 February 2018 
Autophagy enhancers
 21 February 2018 
Management of hemorrhoids in the USA
 21 February 2018 
Adalimumab and infliximab in biologic-naïve Crohn's
 21 February 2018 
Cystic fibrosis and colorectal cancer
 20 February 2018 
Complications and surveillance colonoscopies
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us